Improvements in the HIV care continuum needed to meaningfully reduce HIV incidence among men who have sex with men in Baltimore, US: a modelling study for HPTN 078

Kate M. Mitchell, Brooke Hoots, Dobromir Dimitrov, Danielle German, Colin Flynn, Jason Farley, Marcy Gelman, James P. Hughes, Deborah Donnell, Adeola Adeyeye, Robert H. Remien, Christopher Beyrer, Gabriela Paz-Bailey, Marie Claude Boily

Research output: Contribution to journalArticle

Abstract

Introduction: HIV prevalence is high among men who have sex with men (MSM) in Baltimore, Maryland, United States, and the levels of viral suppression among HIV-positive MSM are relatively low. The HIV Prevention Trials Network 078 trial seeks to increase the levels of viral suppression among US MSM by increasing the rates of diagnosis and linkage to care and treatment. We estimated the increases in viral suppression needed to reach different HIV incidence reduction targets, and the impact of meeting diagnosis and treatment targets. Methods: We used a mathematical model of HIV transmission among MSM from Baltimore, US, parameterised with behavioural data and fitted to HIV prevalence and care continuum data for Baltimore wherever possible, to project increases in viral suppression needed to reduce the HIV incidence rate among Baltimore MSM by 10, 20, 30 or 50% after 2, 5 and 10 years. We also projected HIV incidence reductions achieved if US national targets – 90% of people living with HIV (PLHIV) know their HIV serostatus, 90% of those diagnosed are retained in HIV medical care and 80% of those diagnosed are virally suppressed – or UNAIDS 90-90-90 targets (90% of PLHIV know their status, 90% of those diagnosed receive antiretroviral therapy (ART), 90% of those receiving ART are virally suppressed) are each met by 2020. Results: To reduce the HIV incidence rate by 20% and 50% after five years (compared with the base-case at the same time point), the proportion of all HIV-positive MSM who are virally suppressed must increase above 2015 levels by a median 13 percentage points (95% uncertainty interval 9 to 16 percentage points) from median 49% to 60%, and 27 percentage points (22 to 35) from 49% to 75% respectively. Meeting all three US or 90-90-90 UNAIDS targets results in a 48% (31% to 63%) and 51% (38% to 65%) HIV incidence rate reduction in 2020 respectively. Conclusions: Substantial improvements in levels of viral suppression will be needed to achieve significant incidence reductions among MSM in Baltimore, and to meet 2020 US and UNAIDS targets. Future modelling studies should additionally consider the impact of pre-exposure prophylaxis for MSM.

Original languageEnglish (US)
Article numbere25246
JournalJournal of the International AIDS Society
Volume22
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Baltimore
Continuity of Patient Care
HIV
Incidence
Therapeutics

Keywords

  • forecasting
  • HIV infections
  • homosexuality, male
  • incidence
  • models, theoretical
  • United States

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Improvements in the HIV care continuum needed to meaningfully reduce HIV incidence among men who have sex with men in Baltimore, US : a modelling study for HPTN 078. / Mitchell, Kate M.; Hoots, Brooke; Dimitrov, Dobromir; German, Danielle; Flynn, Colin; Farley, Jason; Gelman, Marcy; Hughes, James P.; Donnell, Deborah; Adeyeye, Adeola; Remien, Robert H.; Beyrer, Christopher; Paz-Bailey, Gabriela; Boily, Marie Claude.

In: Journal of the International AIDS Society, Vol. 22, No. 3, e25246, 01.03.2019.

Research output: Contribution to journalArticle

Mitchell, Kate M. ; Hoots, Brooke ; Dimitrov, Dobromir ; German, Danielle ; Flynn, Colin ; Farley, Jason ; Gelman, Marcy ; Hughes, James P. ; Donnell, Deborah ; Adeyeye, Adeola ; Remien, Robert H. ; Beyrer, Christopher ; Paz-Bailey, Gabriela ; Boily, Marie Claude. / Improvements in the HIV care continuum needed to meaningfully reduce HIV incidence among men who have sex with men in Baltimore, US : a modelling study for HPTN 078. In: Journal of the International AIDS Society. 2019 ; Vol. 22, No. 3.
@article{1a0c10ff20b94ab8b5f2f55d9a900021,
title = "Improvements in the HIV care continuum needed to meaningfully reduce HIV incidence among men who have sex with men in Baltimore, US: a modelling study for HPTN 078",
abstract = "Introduction: HIV prevalence is high among men who have sex with men (MSM) in Baltimore, Maryland, United States, and the levels of viral suppression among HIV-positive MSM are relatively low. The HIV Prevention Trials Network 078 trial seeks to increase the levels of viral suppression among US MSM by increasing the rates of diagnosis and linkage to care and treatment. We estimated the increases in viral suppression needed to reach different HIV incidence reduction targets, and the impact of meeting diagnosis and treatment targets. Methods: We used a mathematical model of HIV transmission among MSM from Baltimore, US, parameterised with behavioural data and fitted to HIV prevalence and care continuum data for Baltimore wherever possible, to project increases in viral suppression needed to reduce the HIV incidence rate among Baltimore MSM by 10, 20, 30 or 50{\%} after 2, 5 and 10 years. We also projected HIV incidence reductions achieved if US national targets – 90{\%} of people living with HIV (PLHIV) know their HIV serostatus, 90{\%} of those diagnosed are retained in HIV medical care and 80{\%} of those diagnosed are virally suppressed – or UNAIDS 90-90-90 targets (90{\%} of PLHIV know their status, 90{\%} of those diagnosed receive antiretroviral therapy (ART), 90{\%} of those receiving ART are virally suppressed) are each met by 2020. Results: To reduce the HIV incidence rate by 20{\%} and 50{\%} after five years (compared with the base-case at the same time point), the proportion of all HIV-positive MSM who are virally suppressed must increase above 2015 levels by a median 13 percentage points (95{\%} uncertainty interval 9 to 16 percentage points) from median 49{\%} to 60{\%}, and 27 percentage points (22 to 35) from 49{\%} to 75{\%} respectively. Meeting all three US or 90-90-90 UNAIDS targets results in a 48{\%} (31{\%} to 63{\%}) and 51{\%} (38{\%} to 65{\%}) HIV incidence rate reduction in 2020 respectively. Conclusions: Substantial improvements in levels of viral suppression will be needed to achieve significant incidence reductions among MSM in Baltimore, and to meet 2020 US and UNAIDS targets. Future modelling studies should additionally consider the impact of pre-exposure prophylaxis for MSM.",
keywords = "forecasting, HIV infections, homosexuality, male, incidence, models, theoretical, United States",
author = "Mitchell, {Kate M.} and Brooke Hoots and Dobromir Dimitrov and Danielle German and Colin Flynn and Jason Farley and Marcy Gelman and Hughes, {James P.} and Deborah Donnell and Adeola Adeyeye and Remien, {Robert H.} and Christopher Beyrer and Gabriela Paz-Bailey and Boily, {Marie Claude}",
year = "2019",
month = "3",
day = "1",
doi = "10.1002/jia2.25246",
language = "English (US)",
volume = "22",
journal = "Journal of the International AIDS Society",
issn = "1758-2652",
publisher = "International AIDS Society",
number = "3",

}

TY - JOUR

T1 - Improvements in the HIV care continuum needed to meaningfully reduce HIV incidence among men who have sex with men in Baltimore, US

T2 - a modelling study for HPTN 078

AU - Mitchell, Kate M.

AU - Hoots, Brooke

AU - Dimitrov, Dobromir

AU - German, Danielle

AU - Flynn, Colin

AU - Farley, Jason

AU - Gelman, Marcy

AU - Hughes, James P.

AU - Donnell, Deborah

AU - Adeyeye, Adeola

AU - Remien, Robert H.

AU - Beyrer, Christopher

AU - Paz-Bailey, Gabriela

AU - Boily, Marie Claude

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Introduction: HIV prevalence is high among men who have sex with men (MSM) in Baltimore, Maryland, United States, and the levels of viral suppression among HIV-positive MSM are relatively low. The HIV Prevention Trials Network 078 trial seeks to increase the levels of viral suppression among US MSM by increasing the rates of diagnosis and linkage to care and treatment. We estimated the increases in viral suppression needed to reach different HIV incidence reduction targets, and the impact of meeting diagnosis and treatment targets. Methods: We used a mathematical model of HIV transmission among MSM from Baltimore, US, parameterised with behavioural data and fitted to HIV prevalence and care continuum data for Baltimore wherever possible, to project increases in viral suppression needed to reduce the HIV incidence rate among Baltimore MSM by 10, 20, 30 or 50% after 2, 5 and 10 years. We also projected HIV incidence reductions achieved if US national targets – 90% of people living with HIV (PLHIV) know their HIV serostatus, 90% of those diagnosed are retained in HIV medical care and 80% of those diagnosed are virally suppressed – or UNAIDS 90-90-90 targets (90% of PLHIV know their status, 90% of those diagnosed receive antiretroviral therapy (ART), 90% of those receiving ART are virally suppressed) are each met by 2020. Results: To reduce the HIV incidence rate by 20% and 50% after five years (compared with the base-case at the same time point), the proportion of all HIV-positive MSM who are virally suppressed must increase above 2015 levels by a median 13 percentage points (95% uncertainty interval 9 to 16 percentage points) from median 49% to 60%, and 27 percentage points (22 to 35) from 49% to 75% respectively. Meeting all three US or 90-90-90 UNAIDS targets results in a 48% (31% to 63%) and 51% (38% to 65%) HIV incidence rate reduction in 2020 respectively. Conclusions: Substantial improvements in levels of viral suppression will be needed to achieve significant incidence reductions among MSM in Baltimore, and to meet 2020 US and UNAIDS targets. Future modelling studies should additionally consider the impact of pre-exposure prophylaxis for MSM.

AB - Introduction: HIV prevalence is high among men who have sex with men (MSM) in Baltimore, Maryland, United States, and the levels of viral suppression among HIV-positive MSM are relatively low. The HIV Prevention Trials Network 078 trial seeks to increase the levels of viral suppression among US MSM by increasing the rates of diagnosis and linkage to care and treatment. We estimated the increases in viral suppression needed to reach different HIV incidence reduction targets, and the impact of meeting diagnosis and treatment targets. Methods: We used a mathematical model of HIV transmission among MSM from Baltimore, US, parameterised with behavioural data and fitted to HIV prevalence and care continuum data for Baltimore wherever possible, to project increases in viral suppression needed to reduce the HIV incidence rate among Baltimore MSM by 10, 20, 30 or 50% after 2, 5 and 10 years. We also projected HIV incidence reductions achieved if US national targets – 90% of people living with HIV (PLHIV) know their HIV serostatus, 90% of those diagnosed are retained in HIV medical care and 80% of those diagnosed are virally suppressed – or UNAIDS 90-90-90 targets (90% of PLHIV know their status, 90% of those diagnosed receive antiretroviral therapy (ART), 90% of those receiving ART are virally suppressed) are each met by 2020. Results: To reduce the HIV incidence rate by 20% and 50% after five years (compared with the base-case at the same time point), the proportion of all HIV-positive MSM who are virally suppressed must increase above 2015 levels by a median 13 percentage points (95% uncertainty interval 9 to 16 percentage points) from median 49% to 60%, and 27 percentage points (22 to 35) from 49% to 75% respectively. Meeting all three US or 90-90-90 UNAIDS targets results in a 48% (31% to 63%) and 51% (38% to 65%) HIV incidence rate reduction in 2020 respectively. Conclusions: Substantial improvements in levels of viral suppression will be needed to achieve significant incidence reductions among MSM in Baltimore, and to meet 2020 US and UNAIDS targets. Future modelling studies should additionally consider the impact of pre-exposure prophylaxis for MSM.

KW - forecasting

KW - HIV infections

KW - homosexuality, male

KW - incidence

KW - models, theoretical

KW - United States

UR - http://www.scopus.com/inward/record.url?scp=85062884281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062884281&partnerID=8YFLogxK

U2 - 10.1002/jia2.25246

DO - 10.1002/jia2.25246

M3 - Article

C2 - 30868739

AN - SCOPUS:85062884281

VL - 22

JO - Journal of the International AIDS Society

JF - Journal of the International AIDS Society

SN - 1758-2652

IS - 3

M1 - e25246

ER -